Middle East & Africa Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by types (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), application (Neurologic Conditions

Middle East & Africa Transdermal Medical Patch Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by types (Single Layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Reservoir, Vapor Patch, and Matrix), application (Neurologic Conditions, Pain Management, Nicotine Cessation, Cardiovascular Disorders, Hormonal Therapy, and Others), and distribution channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

Middle East & Africa transdermal medical patch market is expected to grow from US$ 212.17 million in 2023 to US$ 239.75 million by 2028. It is estimated to grow at a CAGR of 2.5% from 2023 to 2028.

Increasing Strategic Initiatives Fuels Middle East & Africa Transdermal Medical Patch Market

Products facilitating self-administration and home care drug delivery systems, as well as growing pharmaceutical company partnerships, are likely to accelerate the adoption of transdermal medical patches in the upcoming years. In February 2023, DuPont Healthcare collaborated with TNO Holst Centre and Pronat Medical to develop a new wearable medical adhesive concept patch for monitoring, diagnostics, or treatment. In December 2022, Henkel collaborated with Quad Industries to create a new concept enabling faster development of health patches for the medical industry.

Therefore, innovative technologies for medical patches are highly valued due to the enormous market growth potential and the need to improve the performance of these patches positively impact patient comfort and compliance. Such strategic initiatives will likely offer growth opportunities to market players and assist in attaining a significant position in the transdermal medical patch market.

Middle East & Africa Transdermal Medical Patch Market Overview

The transdermal medical patch market in the Middle East & Africa is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The regional growth is attributed to growing research on cancer and gene mutations, increasing disease modeling, and developments by market players offering transdermal medical patch. Factors such as the increasing prevalence of diabetes and other chronic diseases and initiatives of the government and other organizations to spread awareness among people. Additionally, increasing efforts of companies toward adopting medical patch technology are contributing to the growth of the transdermal medical patch market in the Middle East & Africa.

Middle East & Africa Transdermal Medical Patch Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Transdermal Medical Patch Market Segmentation

The Middle East & Africa transdermal medical patch market is segmented into type, application, distribution channels and country.

Based on type, the Middle East & Africa transdermal medical patch market is segmented into single-layer drug in-adhesive, multi-layer drug in-adhesive, reservoir, vapor patch and matrix. The matrix registered the largest market share in Middle East & Africa transdermal medical patch market in 2023.

Based on application, the Middle East & Africa transdermal medical patch market is segmented into neurologic conditions, pain management, nicotine cessation, cardiovascular disorders, hormonal therapy, and others. The pain management segment the largest market share in 2023.

Based on distribution channels, the Middle East & Africa transdermal medical patch market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest market share in 2023.

Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa. Saudi Arabia dominated the market share in 2023.

Boehringer Ingelheim International GmbH; Endo International Inc; Hisamitsu Pharmaceutical Co Inc; Johnsons and Johnsons; Medline Industries LP; Novartis AG; Teva Pharmaceutical Industries Ltd.; and Viatris Inc are the leading companies operating in the transdermal medical patch market in the region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa transdermal medical patch market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa transdermal medical patch market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the transdermal medical patch market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution